BioWorld MedTech

June 15, 2011

CerebralRx enters market with vagus nerve stimulation device

CerebralRx, a newly formed spin-off of BioControl Medical (both Yehud, Israel), is hitting the ground running with the launch of its FitNeS vagus nerve stimulation system for epilepsy in Europe. (Medical Device Daily) Read More

Washington roundup: FDA's new nanoscale materials guidance sets bar at 1,000 nm

International report: Medical Care Technologies expands Chinese operations

Device gives hospitals early sense of patient's condition

Financings roundup: UHS to offer $175M of second lien toggle notes

Med-Tech Notes

Agreements/contracts: pSivida amends glaucoma R&D development with Pfizer

HIT roundup: Premier releases PhysicianFocus for performance improvement

Patent watch: Biomoda expands use of assay with new patent

Grants roundup: Precision Medical receives QTDP grant for UI device

Product Briefs

People in the News

MDD's Oncology Extra

Today's news in brief

BioWorld

Precision psychiatry beyond, or before, biomarkers

BioWorld

There is broad agreement that psychiatric diagnoses in their current form are not reflective of any underlying biology, and that this is one of the things...

ADPD 2026: Can we prevent dementia? Scientists quantify it

BioWorld

Neurodegenerative disease and cognitive decline cannot be explained by a single process. Beta-amyloid plaques, hyperphosphorylated tau, alpha-synuclein, activated...

First-in-class POLG activator restores mtDNA across mutations

BioWorld Science

Researchers from Pretzel Therapeutics Inc. presented preclinical data of PX-578, a first-in-class POLG activator aimed at restoring mtDNA replication and...

News in brief

BioWorld Asia

BioWorld Asia briefs for March 17, 2026